Franklin Resources Inc Ngm Biopharmaceuticals Inc Transaction History

Franklin Resources Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.05 - $3.37 $20,304 - $65,169	-19,338 Reduced 57.83%	14,100 $15,000
Q2 2023 Aug 11, 2023	BUY	$2.44 - $4.53 $81,588 - $151,474	33,438 New	33,438 $86,000
Q4 2022 Feb 10, 2023	BUY	$3.41 - $12.93 $56,265 - $213,345	16,500 New	16,500 $82,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.